The EXCLAIM study: Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with restricted mobility.

被引：0
|
作者：
Hull, R
Tapson, VF
Schellong, S
Yusen, RD
Monreal, M
Samama, MM
Turpie, AGG
Wildgoose, P
Cort, S
机构：
[1] Univ Calgary, Foothills Hosp, Calgary, AB T2N 1N4, Canada
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
[3] Universitatsklinikum Carl Gustav Carus, Med Klin & Poliklin 3, Dresden, Germany
[4] Washington Univ, Sch Med, St Louis, MO 63130 USA
[5] Hosp Germans Trias & Pujol, Barcelona, Spain
[6] Serv Hematol Biol, Paris, France
[7] McMaster Univ, HHSC McMaster Clin, Hamilton, ON L8S 4L8, Canada
[8] Aventis Pharma, Bridgewater, NJ USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4208
引用
收藏
页码：125B / 125B
页数：1
相关论文
共 50 条
  • [21] Identifying acutely ill medical patients requiring thromboprophylaxis
    Chopard, P
    Spirk, D
    Bounameaux, H
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) : 915 - 916
  • [22] The effects of the degree of mobility reduction and prespecified risk factors on venous thromboembolism rates in acutely ill medical patients in the EXCLAIM study
    Yusen, Roger D.
    Hull, Russell D.
    Schellong, Sebastian M.
    Tapson, Victor F.
    Monreal, Manuel
    Samama, Meyer-Michel
    Turpie, Alexander G. G.
    BLOOD, 2007, 110 (11) : 551A - 551A
  • [23] Thromboprophylaxis with enoxaparin in Germany -: Two surveys totalling 13165 acutely ill medical outpatients
    Kroeger, K.
    Paar, W. D.
    PHLEBOLOGIE, 2006, 35 (06) : 281 - 285
  • [24] Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis
    Cimminiello, Claudio
    Prandoni, Paolo
    Agnelli, Giancarlo
    Di Minno, Giovanni
    Friz, Hernan Polo
    Scaglione, Francesco
    Boracchi, Patrizia
    Marano, Giuseppe
    Harenberg, Job
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (08) : 1291 - 1305
  • [25] Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis
    Claudio Cimminiello
    Paolo Prandoni
    Giancarlo Agnelli
    Giovanni Di Minno
    Hernan Polo Friz
    Francesco Scaglione
    Patrizia Boracchi
    Giuseppe Marano
    Job Harenberg
    Internal and Emergency Medicine, 2017, 12 : 1291 - 1305
  • [26] Another good reason for not ignoring thromboprophylaxis in acutely ill medical patients
    Ageno, W
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) : 1889 - 1891
  • [27] Enoxaparin thrombophylaxis did not reduce mortality in acutely ill medical patients
    Feinbloom, David
    Bauer, Kenneth A.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (08)
  • [28] Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies
    Spyropoulos, Alex C.
    Lipardi, Concetta
    Cohen, Alexander T.
    Vuckovic, Biljana
    Xu, Jianfeng
    Lu, Wentao
    Spiro, Theodore E.
    Barnathan, Elliot S.
    Raskob, Gary E.
    BLOOD, 2019, 134
  • [29] The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely III Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study
    Yusen, Roger D.
    Hull, Russell D.
    Schellong, Sebastian M.
    Tapson, Victor F.
    Monreal, Manuel
    Samama, Michel Meyer
    Chen, Min
    Turpie, Alexander G. G.
    BLOOD, 2008, 112 (11) : 167 - 167
  • [30] Thromboprophylaxis of venous thromboembolism in acutely ill medical patients with enoxaparin - Consistency of treatment effect across disease groups: The MEDENOX trial.
    Cohen, A
    BLOOD, 1999, 94 (10) : 103B - 103B
12345